ProTrading24ru

Moderna nears FDA approval - what's next?

NASDAQ:MRNA   Moderna, Inc.
#MRNA got a positive report of FDA expert commission on its covid vaccine today.
Committee meeting is scheduled for Thursday and vaccine approval may be granted starting from Friday.

It's going to be the most expensive vaccine of all so the sale numbers won't be of a global scale.

Way up to $200 for the #MRNA stock is technically pathed through the correction at $140.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。